TGFB1 and sarcoidosis: Additionally, PDE-4 inhibition may intersect with key fibrotic and inflammatory pathways, including JAK-STAT and TGF-β signaling cascades [13,15], potentially contributing to both anti-inflammatory and anti-fibrotic effects in sarcoidosis.